PROVIDER PROFILE · NPI 1821083379

Craig SmithM.D.

OphthalmologyDallas, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,054

Unique beneficiaries

—

Total services

1,189

Distinct HCPCS

Medicare payment

$102K

Peer benchmark

Total Medicare services vs. 1,238 Ophthalmology providers in TX — below median (cohort median 1,864).

PRESCRIBING · PART D · 2024

Total Rx claims

723

Beneficiaries

—

Total drug cost

$82K

Distinct drugs

Brand share

43.3%

Top prescribed drugs

Tobramycin/Dexamethasone88 claims

Prednisolone Acetate87 claims

Ciprofloxacin Hcl77 claims

Latanoprost75 claims

Bacitracin/Polymyxin B Sulfate74 claims

QUALITY · MIPS · 2024

Final MIPS score

92.3

Quality

0.0

Cost

80.9

Improvement activities

40.0

Promoting interop.

91.0

Payment adjustment

0.73%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$15

Payment records

By payment type

Food and Beverage$15

REFERRAL NETWORK

Where Craig Smith's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	75	116
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	24	34
Park Central Surgical Center, Ltd Ambulatory Surgical Center · Dallas, TX	19	23
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS	17	23
MUIR, JOHN	12	14

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history